johnson and johnson glp-1 J&J CEO sends a clear message on the obesity drug boom GLP-1 therapies are transforming weight

Table 1 Recent studies investigating GLP analogs and DPP-iv inhibitors use in inflammatory bowel disease

The dose-response curve in clinical trials was clean and linear

Hashida R, Kawaguchi T, Bekki M, Omoto M, Matsuse H, Nago T, et al

Research Applications Beyond Weight Loss Although obesity and type 2 diabetes are the headline indications, retatrutides mechanism makes it an interesting research tool for a surprisingly wide range of investigations

However, women can also experience significant benefits from carefully monitored testosterone therapy

This could lower total Medicare spending on semaglutide products, including Ozempic, Rybelsus, and Wegovy